AI Buyer Insights:

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Michelin, an e2open customer evaluated Oracle Transportation Management

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Michelin, an e2open customer evaluated Oracle Transportation Management

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

List of Dassault Medidata Edge CTMS Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight Insight Source
Aperio Clinical Outcomes Professional Services 40 $4M United States Dassault Systemes Dassault Medidata Edge CTMS Clinical Trial Management 2018 n/a In 2018 Aperio Clinical Outcomes expanded its use of the Medidata Clinical Cloud from Dassault Systemes to include Dassault Medidata Edge CTMS within a Clinical Trial Management deployment. The expansion added Edge eTMF and Edge CTMS to Aperio's platform footprint, initiating a unified platform approach for trial documentation and operational tracking. The implementation centralized CTMS capabilities by deploying Dassault Medidata Edge CTMS alongside Edge eTMF on the Medidata Clinical Cloud, aligning study planning, execution tracking, and study close processes. Functional modules implemented include study planning workflows, electronic trial master file management, and trial execution tracking, with content and metadata consolidated on a single cloud platform to reduce fragmentation across research activities. Operational scope covers all aspects of Aperio's clinical research lifecycle from study planning through study close, affecting clinical operations and research delivery functions. Governance and process work focused on consolidating content, workflows and data on the Medidata Clinical Cloud, and the expansion was explicitly intended to allow Aperio to unify its content, workflows and data for all aspects of its research.
Hengrui Life Sciences 24431 $3.3B China Dassault Systemes Dassault Medidata Edge CTMS Clinical Trial Management 2018 n/a In 2018, Hengrui implemented Dassault Medidata Edge CTMS as part of a broader Medidata suite deployment with Dassault Systemes, aligning Clinical Trial Management capabilities to support an emerging market strategy and global drug research. The deployment included Medidata Rave EDC, RTSM, Coder and Safety Gateway alongside Dassault Medidata Edge CTMS to create a unified clinical systems footprint across studies. The Dassault Medidata Edge CTMS implementation focused on core Clinical Trial Management functionality such as study planning and governance, site and subject tracking, monitoring visit scheduling, document and trial master file linkage, and task orchestration for study teams. Configuration emphasized workflow automation for study startup and monitoring processes, protocol deviation logging, and role based access controls to align system behavior with clinical SOPs. Integrations were explicitly implemented between Edge CTMS and Medidata Rave EDC for clinical data flow, RTSM for randomization and supply operations, Coder for automated medical coding, and Safety Gateway for case exchange with pharmacovigilance workflows. Operational coverage centered on clinical operations, clinical data management and safety teams, with the configuration intended to support studies conducted in emerging market sites as part of Hengrui's global research activities. Governance workstreams accompanied the technical rollout, standardizing monitoring and reporting workflows, defining data stewardship and audit trail requirements within the Clinical Trial Management context, and embedding role based governance across cross functional teams. The program emphasized orchestration between CTMS, EDC, RTSM, coding and safety systems to create a consolidated operational model for study execution.
Santen Pharmaceutical Life Sciences 3744 $2.1B Japan Dassault Systemes Dassault Medidata Edge CTMS Clinical Trial Management 2018 n/a In 2018, Santen Pharmaceutical Co., Ltd expanded its use of the Medidata Clinical Cloud and implemented Dassault Medidata Edge CTMS to support clinical trial operations in ophthalmology across Japan, Asia, USA and the EU. Dassault Medidata Edge CTMS was adopted as the enterprise Clinical Trial Management platform to provide centralized oversight for study execution and operational coordination across regional teams. The implementation centered on core Clinical Trial Management capabilities, with the CTMS configured to manage study and site lifecycles, enrollment and milestone tracking, monitoring visit scheduling, investigator and site documentation, and centralized operational reporting. Configuration work emphasized study start up workflows and visibility into ongoing study metrics to support clinical operations and site management in the ophthalmology therapeutic area. The deployment extended existing use of the Medidata Clinical Cloud, integrating Dassault Medidata Edge CTMS into Santen’s clinical technology stack as part of a unified Medidata environment. Operational scope explicitly covered Japan, broader Asia, the USA and the EU, positioning the CTMS to coordinate cross‑regional trials and multisite investigator networks. Santen became the first sponsor to adopt Medidata Edge CTMS in the Japanese market, marking an expansion of its Medidata footprint and a strategic move to standardize clinical trial operations across regions. Governance and workflow alignment focused on embedding CTMS workflows into clinical operations and site oversight processes to support consistent study governance and investigator management.
Showing 1 to 3 of 3 entries

Buyer Intent: Companies Evaluating Dassault Medidata Edge CTMS

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Dassault Medidata Edge CTMS. Gain ongoing access to real-time prospects and uncover hidden opportunities. Companies Actively Evaluating Dassault Medidata Edge CTMS for Clinical Trial Management include:

  1. India.Gov.In, a India based Government organization with 500 Employees
  2. Cipla, a India based Life Sciences company with 30313 Employees
  3. Tandym Group, a United States based Professional Services organization with 300 Employees

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found